[
  {
    "date": "2023-12-31",
    "symbol": "NRSN",
    "period": "FY",
    "cashandcashequivalents": 2640000,
    "othercurrentreceivables": 236000,
    "shorttermdepositsclassifiedascashequivalents": 40000,
    "currentassets": 2916000,
    "propertyplantandequipment": 85000,
    "rightofuseassets": 153000,
    "noncurrentnoncashassetspledgedascollateralforwhichtransfereehasrightbycontractorcustomtosellorrepledgecollateral": 22000,
    "noncurrentassets": 260000,
    "assets": 3176000,
    "tradeandothercurrentpayablestotradesuppliers": 1459000,
    "othercurrentpayables": 2000000,
    "currentliabilities": 3459000,
    "noncurrentleaseliabilities": 73000,
    "noncurrentgovernmentgrants": 1518000,
    "noncurrentliabilities": 1591000,
    "liabilities": 5050000,
    "sharepremium": 30192000,
    "retainedearnings": -32066000,
    "equity": -1874000,
    "equityandliabilities": 3176000,
    "researchanddevelopmentsexpenses": 7588000,
    "generalandadministrativeexpense": 5714000,
    "profitlossfromoperatingactivities": -13302000,
    "financecosts": 2209000,
    "financeincome": 4231000,
    "financeincomecost": 2022000,
    "comprehensiveincome": -11280000,
    "basicearningslosspershare": -0.83,
    "dilutedearningslosspershare": -0.83,
    "increasedecreasethroughsharebasedpaymenttransactions": 2959000,
    "netlossandcomprehensiveloss": -11280000,
    "exerciseofoption": 5000,
    "exerciseofprefundedwarrants": 1670000,
    "profitloss": -11280000,
    "adjustmentsfordepreciationexpense": 97000,
    "adjustmentsforsharebasedpayments": 2798000,
    "adjustmentsforfairvaluegainslosses": -4036000,
    "day1lossfromissuanceoffinancialinstruments": 1659000,
    "financeexpenseincome": -402000,
    "increaseinotherreceivables": -19000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": 961000,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": 928000,
    "cashflowsfromusedinoperatingactivities": -8452000,
    "interestreceivedclassifiedasinvestingactivities": 178000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 29000,
    "cashflowsfromusedindecreaseincreaseinshorttermdepositsandinvestments": 3500000,
    "investmentinrestricteddeposits": 3000,
    "cashflowsfromusedininvestingactivities": 3646000,
    "proceedsfromexerciseofoptions": 5000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 80000,
    "proceedsfromissuingshares": 3970000,
    "cashflowsfromusedinfinancingactivities": 3895000,
    "effectofexchangeratechangesoncashandcashequivalents": 8000,
    "increasedecreaseincashandcashequivalents": -903000,
    "cashandcashequivalentsclassifiedaspartofdisposalgroupheldforsale": 2640000,
    "sharebasedpaymentmodification": 161000,
    "proceedsfromexerciseofwarrants": 823000,
    "scheduleofregardingtheexchangerateofthenewisraelishekeltabletextblock": "Below are details regarding the exchangerate of the New Israeli Shekel (“NIS”), the Euro and the GBP:",
    "scheduleofcash": "December 31, 2023      December 31, 2022             U.S. dollars in thousands       Denominated in NIS     $107      $229       Denominated in USD      *2,533      3,309       Denominated in EUR      -       1       Denominated in GBP      -       4             $2,640      $3,543",
    "disclosureofotherreceivablestabletextbock": "December 31,    2023              December 31,    2022                     U.S. dollars    in thousands            Government agencies         $    29              $    24           Prepaid expenses              70                   124           Other              137                   107                     $    236              $    255",
    "scheduleofpublicpropertyplantandequipmenttabletextblock": "Balance as of December 31, 2023:",
    "disclosureofmaturityanalysisofleaseliabilitytabletextblock": "Maturity analysis of the Company’s lease liabilities",
    "scheduleofweightedaverageremainingleasetermsanddiscountratetabletextblock": "The following is a summary of weighted average remaininglease terms and discount rate for Company’s leases:",
    "scheduleofamountsrecognizedinprofitorlosstabletextblock": "The following are the amounts recognized in profit or loss:",
    "scheduleofleasepaymentstabletextblock": "Presented hereunder are the lease payments the Company paidin the year ended December 31, 2023, 2022 and 2021:",
    "disclosurescheduleofotherpayablestabletextblock": "December 31,             2023      2022             U.S. dollars in thousands       Employees and payroll accruals (*)     $1,317      $751       Short term lease liability      69       64       Accrued expenses      614       413             $2,000      $1,228",
    "scheduleoffairvalueoftheoptionsgrantedtabletextblock": "The following table lists the inputsused for calculation of fair value of the options granted to employees and directors for the years ended December 31, 2023, 2022 and2021:",
    "scheduleofrestrictedstockunitrsusactivityexplanatory": "The following table summarizes the RSU’s activityfor the annual periods ended on December 31, 2023 and 2022:",
    "scheduleofsharebasedexpenserecognizedinthestatementsofincometabletextblock": "The share-based expense recognized in the statements ofincome were as follows:",
    "scheduleofresearchanddevelopmentexpensestabletextblock": "For the year ended December 31,             2023      2022      2021             U.S. dollars in thousands       Subcontractors and consultants     $4,793      $3,612      $628       Share-based compensation      889       1,592       1,969       Salaries and social benefits (see also note 12)      1,905       1,212       447       Others      1       -       38             $7,588      $6,416      $3,082",
    "scheduleofgeneralandadministrativeexpensestabletextblock": "For the year ended December 31,             2023      2022      2021             U.S. dollars in thousands       Professional services     $1,486      $1,085      $372       Share-based compensation      1,909       3,513       1,849       Salaries and social benefits (*)      1,011       837       74       Insurance      511       1,174       68       Traveling abroad      164       165       50       Others      633       362       92             $5,714      $7,136      $2,505",
    "scheduleofbalanceswithrelatedpartiestabletextblock": "A.",
    "scheduleoftransactionswithrelatedpartiestabletextblock": "B.",
    "scheduleofactstoreducetheforeignexchangerisktabletextblock": "The Company acts to reduce the foreignexchange risk by managing an adequate part of the available liquid sources in or linked to the NIS.",
    "disclosureofmovementinwarrantliabilityexplanatory": "The following table summarizes the movement in warrant liability during2023 and 2022:",
    "closingforeignexchangerate": 1.1,
    "exchangeratepercentage": 0.025,
    "estimatedusefullivesterm": 0.33,
    "explanationoffactthatcarryingamountofgoodwillorintangibleassetswithindefiniteusefullivesisnotsignificant": "The shorter of the lease term and the useful life",
    "cash": 107000,
    "governmentagencies": 29000,
    "currentprepaidexpenses": 70000,
    "otherreceivables": 137000,
    "tradeandotherreceivables": 236000,
    "costbalances": 92000,
    "amountsincurreddeferredacquisitioncostsarisingfrominsurancecontracts": 26000,
    "accumulatedothercomprehensiveincome": 34000,
    "depreciationpropertyplantandequipment": 20000,
    "depreciatedcost": 58000,
    "depreciationrightofuseassets": 76000,
    "grossleaseliabilities": 69000,
    "currentleaseliabilities": 69000,
    "weightedaveragedurationofdefinedbenefitobligation2019": "P2Y",
    "weightedaveragediscountrate": 0.06,
    "interestexpenseonleaseliabilities": 11000,
    "amortisationexpense": 76000,
    "otheradjustmentstoreconcileprofitloss": 87000,
    "leasepayments": 80000,
    "leasepaymentstotal": 80000,
    "shorttermemployeebenefitsaccruals": 1317000,
    "shorttermleaseliability": 69000,
    "currentaccruedexpensesandothercurrentliabilities": 614000,
    "otherpayables": 2000000,
    "numberofsharesauthorised": 60000000,
    "numberofsharesissuedandpaid": 15379042,
    "numberofsharesissuedandfullypaid": 15379042,
    "vestedrestrictedstockunits": -467479,
    "issuedforcashduringtheperiod": 3600,
    "exerciseofsharewarrantsandoptionsduringtheyear": -126000,
    "issuanceofshares": 1330000,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.918,
    "exercisepriceshareoptionsgranted2019": 0.96,
    "weightedaveragesharepriceshareoptionsgranted2019": 0.96,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0435,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P10Y",
    "numberofoutstandingshareoptions": 1069128,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 2.34,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 82628,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 1.1,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 126000,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.03,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 48000,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 2.09,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 652878,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 2.32,
    "numberofoutstandingshareoption": 317000,
    "researchanddevelopmentexpense": 889000,
    "sellinggeneralandadministrativeexpense": 1909000,
    "subcontractorsandconsultants": 4793000,
    "sharebasedcompensation": 889000,
    "salariesandsocialbenefits": 1905000,
    "researchanddevelopmentexpenseothers": 1000,
    "researchanddevelopmentexpensestotal": 7588000,
    "professionalfeesexpense": 1486000,
    "sharesbasedcompensation": 1909000,
    "benefitspaidorpayable": 1011000,
    "insuranceexpense": 511000,
    "travelexpense": 164000,
    "otherexpensebynature": 633000,
    "othergainslosses": 5714000,
    "revaluationofwarrants": 4036000,
    "interestincomeondeposits": 178000,
    "gainslossesonexchangedifferencesontranslationnetoftax": 17000,
    "reclassificationadjustmentsonexchangedifferencesontranslationnetoftax": 4231000,
    "insurancefinanceincomeexpensesfrominsurancecontractsissuedexcludedfromprofitorlossthatwillbereclassifiedtoprofitorlossnetoftax": -530000,
    "interestsexpensesonleaseliability": -11000,
    "othercomprehensiveincomenetoftaxinsurancefinanceincomeexpensesfrominsurancecontractsissuedexcludedfromprofitorlossthatwillbereclassifiedtoprofitorloss": -9000,
    "shareofothercomprehensiveincomeofassociatesandjointventuresaccountedforusingequitymethodthatwillbereclassifiedtoprofitorlossnetoftax": -2209000,
    "tradeandothercurrentpayables": 1012000,
    "amountspayablerelatedpartytransactions": 1012000,
    "wagesandsalaries": 1932000,
    "dividendspaid": 310000,
    "keymanagementpersonnelcompensationsharebasedpayment": 2503000,
    "purchasesofgoodsrelatedpartytransactions": 4745000,
    "numberofrelatedparties": 5000,
    "numberofdirectors": 5000,
    "sharesofordinaryshareusedincomputingbasicnetlosspershare": 13640168,
    "sharesofordinaryshareusedincomputingdilutednetlosspershare": 13640168,
    "weightedaveragenumberofordinaryshares": 11781963,
    "dilutiveeffectofshareoptionsonnumberofordinaryshares": 929334,
    "increasedecreaseinnumberofordinarysharesissued": 928871,
    "cashonhand": 2533000,
    "longtermdeposits": 40,
    "othernoncurrentfinancialassets": 22,
    "financialliabilities": 73,
    "financialliabilitiesatfairvalue": 1518000,
    "totalnetexposureinstatementoffinancialpositioninrespectoffinancialassetsandfinanciallia": -703000,
    "profitlossattributabletoownersofparent": -134000,
    "profitlossattributabletoordinaryequityholdersofparententityincludingdilutiveeffects": -134000,
    "expectedlife": "P4Y5M19D",
    "warrantliabilityrecognition": 4500000,
    "fairvaluerevaluationwarrantliability": -4036000,
    "adjustmentsforfinancecosts": 1659000,
    "exerciseinwarrantliability": -823000,
    "numberofemployee": 16,
    "rentalincome": 7000,
    "liabilitiesfromsharebasedpaymenttransactions2011": 209000,
    "sharepurchaseagreements": "a.",
    "warrantstoinvestorsdescription": "In August and September 2021after the said assignments, the Company received warrant exercise notices of 1,837,500 warrants, out of the total 2,130,000 warrantsoutstanding at that time. The other 292,500 warrants that were not exercised were waived by their owners. As a result of the saidexercises, the Company received aggregate proceeds of $1,225 thousand.",
    "numberofsharesoutstanding": 3600,
    "othernoncurrentreceivables": 47000,
    "netproceedsfromoffering": 9864000,
    "exerciseofunderwritersoption": 3000,
    "grossproceed": 7000,
    "immediatelossamount": 1659000,
    "considerationwarrantsandprefundedwarrantamount": 4500000,
    "ordinarysharesvotingrights": "Each ordinary share is entitled toone vote.",
    "expirationdateoftheoptionsgrantedtoemployeesanddirectors": "P10Y",
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 1151130,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailablegrant": 233543,
    "weightedaveragecostofcapitalpercentage": 0.6,
    "pensionfunds": 104000,
    "annualinterestrate": 0.023,
    "warrantsoutstandingshares": 4755000,
    "percentageoftaxrates": 0.23,
    "gainslossesonchangeinvalueofforwardelementsofforwardcontractsbeforetax": 17420000,
    "entityregistrantname": "NeuroSense Therapeutics Ltd.",
    "tradingsymbol": "NRSN",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--12-31",
    "entitycommonstocksharesoutstanding": 15379042,
    "amendmentflag": "false",
    "entitycentralindexkey": 1875091,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-41084",
    "entityincorporationstatecountrycode": "L3",
    "entityaddressaddressline1": "11 HaMenofim Street",
    "entityaddressaddressline2": "Building B",
    "entityaddresscityortown": "Herzliya",
    "entityaddresspostalzipcode": 4672562,
    "entityaddresscountry": "IL",
    "contactpersonnelname": "Or Eisenberg",
    "cityareacode": 972,
    "localphonenumber": "-9-7996183",
    "security12btitle": "Ordinary Shares, no par value per share",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorfirmid": 1057,
    "auditorname": "Somekh Chaikin",
    "auditorlocation": "Tel-Aviv, Israel"
  },
  {
    "date": "2022-12-31",
    "symbol": "NRSN",
    "period": "FY",
    "cashandcashequivalents": 3543000,
    "shorttermdepositsnotclassifiedascashequivalents": 3547000,
    "othercurrentreceivables": 255000,
    "shorttermdepositsclassifiedascashequivalents": 36000,
    "currentassets": 7381000,
    "propertyplantandequipment": 77000,
    "rightofuseassets": 229000,
    "noncurrentnoncashassetspledgedascollateralforwhichtransfereehasrightbycontractorcustomtosellorrepledgecollateral": 23000,
    "noncurrentassets": 329000,
    "assets": 7710000,
    "tradeandothercurrentpayablestotradesuppliers": 498000,
    "othercurrentpayables": 1228000,
    "currentliabilities": 1726000,
    "noncurrentleaseliabilities": 147000,
    "noncurrentgovernmentgrants": 218000,
    "noncurrentliabilities": 365000,
    "liabilities": 2091000,
    "sharepremium": 26405000,
    "retainedearnings": -20786000,
    "equity": 5619000,
    "equityandliabilities": 7710000,
    "researchanddevelopmentsexpenses": 6416000,
    "generalandadministrativeexpense": 7136000,
    "profitlossfromoperatingactivities": -13552000,
    "financecosts": 45000,
    "financeincome": 1257000,
    "financeincomecost": 1212000,
    "comprehensiveincome": -12340000,
    "basicearningslosspershare": -1.07,
    "dilutedearningslosspershare": -1.07,
    "increasedecreasethroughexerciseofwarrantsequity": 4314000,
    "increasedecreasethroughsharebasedpaymenttransactions": 4735000,
    "issueofequity": -96000,
    "netlossandcomprehensiveloss": -12340000,
    "profitloss": -12340000,
    "adjustmentsfordepreciationexpense": 89000,
    "employeebenefitsandsharebasedcompensation": 5105000,
    "adjustmentsforfairvaluegainslosses": -1166000,
    "financeexpenseincome": 24000,
    "increaseinotherreceivables": -55000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": 459000,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": 236000,
    "cashflowsfromusedinoperatingactivities": -7586000,
    "interestreceivedclassifiedasinvestingactivities": 49000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 70000,
    "cashflowsfromusedindecreaseincreaseinshorttermdepositsandinvestments": -3500000,
    "investmentinrestricteddeposits": 20000,
    "cashflowsfromusedininvestingactivities": -3541000,
    "paymentinrespectofcancellationofoptions": -96000,
    "proceedsfromexerciseofoptions": 3870000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 79000,
    "cashflowsfromusedinfinancingactivities": 3695000,
    "effectofexchangeratechangesoncashandcashequivalents": -88000,
    "increasedecreaseincashandcashequivalents": -7520000,
    "cashandcashequivalentsclassifiedaspartofdisposalgroupheldforsale": 3543000,
    "proceedsfromissueofordinaryshares": 306000,
    "proceedsfromexerciseofwarrants": 444000,
    "lesseeleasepolicytextblock": "L. Leases",
    "descriptionofaccountingpolicyforsubsidiarytextblock": "M.Subsidiary",
    "scheduleofregardingtheexchangerateofthenewisraelishekeltabletextblock": "Euro      GBP      NIS       December 31, 2022      1.07       1.20       0.28       December 31, 2021      1.13       1.35       0.32       December 31, 2020      1.22       1.36       0.31       Change in percentages:                              Year ended December 31, 2022      (5.3)      (11.1)      (12.5)      Year ended December 31, 2021      (7.3)      (0.73)      3.2       Year ended December 31, 2020      9.3       3.5       7.5",
    "scheduleofestimatedusefullivestabletextblock": "%       Computers and peripherals and equipment      33       Office furniture and equipment      7 – 15       Leasehold improvements      The shorter of the lease term and the useful life",
    "scheduleofcash": "December 31, 2022      December 31, 2021             U.S. dollars in thousands       Denominated in NIS     $229      $693       Denominated in USD      * 3,309       10,359       Denominated in EUR      1       4       Denominated in GBP      4       7             $3,543      $11,063",
    "disclosureofotherreceivablestabletextbock": "December 31, 2022      December 31, 2021             U.S. dollars in thousands       Government agencies     $24      $102       Prepaid expenses      124       132       Other      107       76             $255      $310",
    "scheduleofamountofcarryingamountsofrightofuseassetsandmovementtabletextblock": "December 31, 2022              U.S.                                            dollars in thousands        Balance as of January 1, 2022     $-       Initial recognition      306       Depreciation on right-of-use-assets      (77)                     Balance as of December 31, 2022     $229",
    "scheduleofamountsrecognizedinprofitorlosstabletextblock": "December 31, 2022             U.S. dollars in thousands       Interest expenses on lease liability      15       Amortization of right-of-use-assets      77                      Total      92",
    "scheduleofcashflowstabletextblock": "Year ended  December 31,2022             U.S. dollars  in thousands                      Repayment of lease liability     $79",
    "disclosurescheduleofotherpayablestabletextblock": "December 31,             2022      2021             U.S. dollars in thousands       Employees and payroll accruals (*)     $751      $115       Short term lease liability      64       -       Accrued expenses      413       443             $1,228      $558",
    "scheduleoffairvalueoftheoptionsgrantedtabletextblock": "2022     2021     2020      Expected volatility     93.51% - 93.79%     91.60%-95.01%     94.00%      Exercise price     1.43-3.97     0.03-5.33     0.03      Share price(1)     1.43 – 3.97     3.72-18.65     1.06      Risk-free interest rate     2.12% - 3.24%     1.42%-1.81%     1%      Dividend yield     0     0     0      Expected life (years)     10     10     10",
    "scheduleoffairvalueoftheunderwriterswarrantsgrantedtabletextblock": "Expected volatility      90.59%      Exercise price     $7.5       Share price(1)     $3.72       Risk-free interest rate      1.23%      Dividend yield      0       Expected life      5",
    "scheduleofsharebasedexpenserecognizedinthestatementsofincometabletextblock": "For the year ended December 31,             2022      2021      2020             U.S. dollars in thousands       Share-based compensation expense – Research and development     $1,592      $1,969      $1,804       Share-based compensation expense – General and administrative      3,513       1,849       257       Share-based compensation expense – Finance expenses      -       341       -             $5,105      $4,159      $2,061",
    "scheduleofresearchanddevelopmentexpensestabletextblock": "For the year ended December 31,             2022      2021      2020             U.S. dollars in thousands       Subcontractors and consultants     $3,612      $628      $     452       Share-based compensation      1,592       1,969       1,804       Salaries and social benefits (*)      1,212       447       227       Others      -       38       12             $6,416      $3,082      $2,495",
    "scheduleofgeneralandadministrativeexpensestabletextblock": "For the year ended December 31,             2022      2021      2020             U.S. dollars in thousands       Professional services     $1,085      $372      $49       Share-based compensation      3,513       1,849       257       Salaries and social benefits (*)      837       74       52       Insurance      1,174       68       14       Traveling abroad      165       50       8       Others      362       92       13             $7,136      $2,505      $393",
    "scheduleofbalanceswithrelatedpartiestabletextblock": "As of December 31,             2022      2021             U.S. dollars in thousands       Other payables – Officers and Directors     $475      $65             $475      $65",
    "scheduleoftransactionswithrelatedpartiestabletextblock": "For the year ended December 31,             2022      2021      2020             U.S. dollars in thousands       Salary fees(1)     $1,140      $257      $126       Directors consultancy fees(2)      310       29       28       Share based payment expense (refer to Note 9)      4,569       1,707       66             $6,019      $1,993      $220       (1) Number of related parties      3       3       1       (2) Number of directors      5       4       4",
    "closingforeignexchangerate": 1.07,
    "changeinpercentagesexchangerate": -5.3,
    "computersandperipheralsandequipment": 0.33,
    "officefurnitureandequipment": 0.07,
    "leaseholdimprovements": "The shorter of the lease term and the useful life",
    "cash": 229000,
    "governmentagencies": 24000,
    "currentprepaidexpenses": 124000,
    "otherreceivable": 107000,
    "tradeandotherreceivables": 255000,
    "costbalances": 66000,
    "amountsincurreddeferredacquisitioncostsarisingfrominsurancecontracts": 58000,
    "accumulatedothercomprehensiveincome": 14000,
    "depreciationpropertyplantandequipment": 10000,
    "costsandexpenses": 52000,
    "liabilitiesarisingfromfinancingactivities": 229000,
    "gainslossesoninitialrecognitionofbiologicalassetsforcurrentperiod": 306000,
    "depreciationrightofuseassets": 77000,
    "maturityleaselessthanoneyear": 64000,
    "maturityleasetwotofouryears": 147000,
    "maturityleasetotal": 211000,
    "otherfinancialliabilities": 64000,
    "financialliabilities": 147000,
    "leasetermyears": "P3Y",
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.06,
    "interestexpenseonleaseliabilities": 15000,
    "amortisationexpense": 77000,
    "otheradjustmentstoreconcileprofitloss": 92000,
    "expenserelatingtovariableleasepaymentsnotincludedinmeasurementofleaseliabilities": 79000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 79000,
    "shorttermemployeebenefitsaccruals": 751000,
    "shorttermleaseliability": 64000,
    "currentaccruedexpensesandothercurrentliabilities": 413000,
    "otherpayables": 1228000,
    "numberofsharesauthorised": 60000000,
    "numberofsharesissuedandpaid": 11781963,
    "numberofsharesissuedandfullypaid": 11781963,
    "issuedforservicesduringtheperiod": 85449,
    "vestedrestrictedstockunits": 107980,
    "exerciseofsharewarrantsandoptionsduringtheyear": 645000,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.9351,
    "exercisepriceshareoptionsgranted2019": 1.43,
    "weightedaveragesharepriceshareoptionsgranted2019": 1.43,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P10Y",
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 2.16,
    "numberofoptionsgranted": 589000,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 1.98,
    "numberofoptionsforfeited": -63000,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 1.26,
    "numberofoptionsoptionsoutstandingending": 1160500,
    "numberofoptionsexercisable": 424000,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 1.64,
    "researchanddevelopmentexpense": 1592000,
    "adjustmentsforsharebasedpayments": 5105000,
    "subcontractorsandconsultants": 3612000,
    "sharebasedcompensation": 1592000,
    "salarieswagesandofficerscompensation": 1212000,
    "researchanddevelopmentexpensestotal": 6416000,
    "professionalfeesexpense": 1085000,
    "sharesbasedcompensation": 3513000,
    "benefitspaidorpayable": 837000,
    "insuranceexpense": 1174000,
    "travelexpense": 165000,
    "otherexpensebynature": 362000,
    "othergainslosses": 7136000,
    "revaluationofwarrants": 1166000,
    "interestincomeondeposits": 91000,
    "reclassificationadjustmentsonexchangedifferencesontranslationnetoftax": 1257000,
    "reclassificationadjustmentsoninsurancefinanceincomeexpensesfrominsurancecontractsissuedexcludedfromprofitorlossnetoftax": -23000,
    "interestsexpensesonleaseliability": -15000,
    "othercomprehensiveincomenetoftaxinsurancefinanceincomeexpensesfrominsurancecontractsissuedexcludedfromprofitorlossthatwillbereclassifiedtoprofitorloss": -7000,
    "shareofothercomprehensiveincomeofassociatesandjointventuresaccountedforusingequitymethodthatwillbereclassifiedtoprofitorlossnetoftax": -45000,
    "tradeandothercurrentpayables": 475000,
    "amountspayablerelatedpartytransactions": 475000,
    "wagesandsalaries": 1140000,
    "dividendspaid": 310000,
    "keymanagementpersonnelcompensationsharebasedpayment": 4569000,
    "purchasesofgoodsrelatedpartytransactions": 6019000,
    "numberofrelatedparties": 3000,
    "numberofdirectors": 5000,
    "sharesofordinaryshareusedincomputingbasicnetlosspershare": 11504521,
    "sharesofordinaryshareusedincomputingdilutednetlosspershare": 11504521,
    "weightedaveragenumberofordinaryshares": 10943534,
    "dilutiveeffectofshareoptionsonnumberofordinaryshares": 517793,
    "increasedecreaseinnumberofordinarysharesissued": 43194,
    "cashonhand": 3309000,
    "shorttermdeposits": 3547000,
    "longtermdeposits": 36,
    "othernoncurrentfinancialassets": 23,
    "currentleaseliabilities": 147,
    "financialliabilitiesatfairvalue": 218000,
    "totalnetexposureinstatementoffinancialpositioninrespectoffinancialassetsandfinanciallia": 5606000,
    "profitlossattributabletoownersofparent": -38000,
    "profitlossattributabletoordinaryequityholdersofparententityincludingdilutiveeffects": -38000,
    "maturityoftimedeposits": "P3M",
    "weightedaveragerateforeigndeposit": 0.023,
    "leaseterm": "P4Y",
    "rentalincome": 7000,
    "additionstorightofuseassets": 306000,
    "liabilitiesfromsharebasedpaymenttransactions2011": 370000,
    "sharepurchaseagreements": "a.",
    "warrantstoinvestorsdescription": "In August and September 2021 afterthe said assignments, the Company received warrant exercise notices of 1,837,500 warrants, out of the total 2,130,000 warrantsoutstanding at that time. The other 292,500 warrants that were not exercised were waived by their owners. As a result of the saidexercises, the Company received aggregate proceeds of $1,225 thousand.",
    "otherreceivables": 47000,
    "netproceedsfromoffering": 9864000,
    "exerciseofunderwritersoption": 3,
    "ordinarysharesvotingrights": "Each ordinary share is entitled toone vote.",
    "expirationdateoftheoptionsgrantedtoemployeesanddirectors": "P10Y",
    "descriptionofemployeeshareoptionplan": "●900,000 shares, plus         ●    An annual increase to be added as of the first day of the Company’s fiscal year, beginning in 2022 and occurring each year thereafter through 2032, equal to 4% of the total number of ordinary shares issued and outstanding on a fully-diluted basis as of the end of the Company’s immediately preceding fiscal year (or such lesser number of shares, including no shares, determined by the board of directors in its sole discretion).",
    "commonstockcapitalharesreservedfutureissuance": 1151130,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailablegrant": 437371,
    "numberofsharesoptionsgrantedinsharebasedpaymentarrangement": 35980,
    "stockoptiongrantedsharepricedescription": "●10,500 options have an exercise price of $1.67 per share. The options vest immediately upon an IPO.         ●    6,000 options have an exercise price of $1.67 per    share. The options vest on December 15, 2021.            ●    6,000 options have an exercise price of $1.67 per    share. The options will on March 15, 2022.",
    "numberofsharesissued": 85449,
    "financialassetsatfairvalue": 119000,
    "restrcitedstockshares": 44000,
    "weightedaveragecostofcapitalpercentage": 0.3,
    "privatetransactiondescription": "The Hybrid Method considered the following future liquidity event scenarios: (1) a stay private scenario (which included a private M&A transaction) and (2) an IPO scenario applying a probability weighting of 60% and 40% to the stay private and the IPO scenarios, respectively, after considering the Company’s stage of development, the stage of IPO discussions and potential volatility in the market.",
    "numberofsharesoutstanding": 144000,
    "reserveofsharebasedpayments": 370000,
    "pensionfunds": 85000,
    "othercashandcashequivalents": 6000000,
    "annualinterestrate": 0.023,
    "percentageoftaxrates": 0.23,
    "gainslossesonchangeinvalueofforwardelementsofforwardcontractsbeforetax": 8640000,
    "entityregistrantname": "NeuroSense Therapeutics Ltd.",
    "tradingsymbol": "NRSN",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--12-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1875091,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-41084",
    "entityincorporationstatecountrycode": "L3",
    "entityaddressaddressline1": "11 HaMenofim Street",
    "entityaddressaddressline2": "Building B",
    "entityaddresscityortown": "Herzliya",
    "entityaddresspostalzipcode": 562,
    "entityaddresscountry": "IL",
    "contactpersonnelname": "Or Eisenberg",
    "cityareacode": 972,
    "localphonenumber": "9-7996183",
    "security12btitle": "Ordinary Shares, no par value per share",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorfirmid": 1057,
    "auditorname": "Somekh Chaikin",
    "auditorlocation": "Tel-Aviv, Israel"
  },
  {
    "date": "2021-12-31",
    "symbol": "NRSN",
    "period": "FY",
    "cashandcashequivalents": 11063000,
    "othercurrentreceivables": 310000,
    "shorttermdepositsclassifiedascashequivalents": 39000,
    "currentassets": 11412000,
    "propertyplantandequipment": 19000,
    "noncurrentassets": 19000,
    "assets": 11431000,
    "tradeandothercurrentpayablestotradesuppliers": 39000,
    "othercurrentpayables": 558000,
    "currentliabilities": 597000,
    "noncurrentgovernmentgrants": 1828000,
    "noncurrentliabilities": 1828000,
    "liabilities": 2425000,
    "issuedcapital": 3720,
    "sharepremium": 17452000,
    "retainedearnings": -8446000,
    "equity": 9006000,
    "equityandliabilities": 11431000,
    "researchanddevelopmentsexpenses": 3082000,
    "generalandadministrativeexpense": 2505000,
    "profitlossfromoperatingactivities": -5587000,
    "financecosts": 1186000,
    "financeincome": 2732000,
    "financeincomecost": 1546000,
    "comprehensiveincome": -4041000,
    "basicearningslosspershare": -0.65,
    "increasedecreasethroughsharebasedpaymenttransactions": 4716000,
    "issuanceofsafeinstruments": 800000,
    "increasedecreasethroughexerciseofwarrantsequity": 1311000,
    "issuanceofordinarysharesnetuponipo": 5561000,
    "netlossandcomprehensiveloss": -4041000,
    "profitloss": -4041000,
    "adjustmentsfordepreciationexpense": 3000,
    "adjustmentsforsharebasedpayments": 4159000,
    "adjustmentsforfairvaluegainslosses": -2732000,
    "adjustmentsforgainlossondisposalspropertyplantandequipment": 8000,
    "financeexpenseincome": -791000,
    "increaseinotherreceivables": 204000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": -16000,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": 493000,
    "cashflowsfromusedinoperatingactivities": -1539000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 17000,
    "cashflowsfromusedininvestingactivities": -17000,
    "issuanceofsafeinstrument": 800000,
    "proceedsfromexerciseofoptions": 1238000,
    "proceedsfromissuingshares": 9864000,
    "cashflowsfromusedinfinancingactivities": 11902000,
    "effectofexchangeratechangesoncashandcashequivalents": 18000,
    "increasedecreaseincashandcashequivalents": 10364000,
    "cashandcashequivalentsclassifiedaspartofdisposalgroupheldforsale": 11063000,
    "exerciseofoptions": 76000,
    "scheduleofregardingtheexchangerateofthenewisraelishekeltabletextblock": "Euro      GBP      NIS       December 31, 2021      1.13       1.35       0.32       December 31, 2020      1.22       1.36       0.31       December 31, 2019      1.12       1.32       0.29       Change in percentages:                              Year ended December 31, 2021      (7.3)      (0.73)      3.2       Year ended December 31, 2020      9.3       3.5       7.5       Year ended December 31, 2019      (2)      3.2       8.4",
    "scheduleofestimatedusefullivestabletextblock": "%      Computers and peripherals and equipment         33      Office furniture and equipment         7 – 15      Leasehold improvements         The shorter of the lease term and the useful life",
    "scheduleofcash": "December 31, 2021      December 31, 2020             U.S. dollars in thousands      U.S. dollars in thousands       Denominated in NIS     $693      $384       Denominated in USD      10,359       250       Denominated in EUR      4       58       Denominated in GBP      7       7             $11,063      $699",
    "disclosureofotherreceivablestabletextbock": "December 31, 2021      December 31, 2020             U.S. dollars in thousands      U.S. dollars in thousands       Government agencies     $102      $30       Prepaid expenses      132       -       Other      76       -             $310      $30",
    "disclosurescheduleofotherpayablestabletextblock": "December 31,             2021      2020             U.S. dollars in thousands      U.S. dollars in thousands       Employees and payroll accruals     $115      $36       Accrued expenses      443       29             $558      $65",
    "scheduleoffairvalueoftheunderwriterswarrantsgrantedtabletextblock": "Expected volatility              90.59%            Exercise price              $7.5           Share price(1)              $3.72           Risk-free interest rate              1.23%            Dividend yield              0           Expected life              5",
    "scheduleofsharebasedexpenserecognizedinthestatementsofincometabletextblock": "For the year ended December 31,             2021      2020      2019             U.S. dollars in thousands       Share-based compensation expense – Research and development     $1,969      $1,804       474       Share-based compensation expense – General and administrative      1,849       257       137       Share-based compensation expense – Finance expenses      341       -       -             $4,159      $2,061       611",
    "scheduleofresearchanddevelopmentexpensestabletextblock": "For the year ended December 31,             2021      2020      2019             U.S. dollars in thousands       Subcontractors and consultants     $628      $452      $304       Share-based compensation      1,969       1,804       474       Salaries and social benefits      447       227       105       Others      38       12       15             $3,082      $2,495      $898",
    "scheduleofgeneralandadministrativeexpensestabletextblock": "For the year ended December 31,             2021      2020      2019             U.S. dollars in thousands       Professional services     $372      $49      $111       Share-based compensation      1,849       257       137       Salaries and social benefits      74       52       56       Insurance      68       14       6       Traveling abroad      50       8       24       Others      92       13       3             $2,505      $393      $337",
    "scheduleofbalanceswithrelatedpartiestabletextblock": "As of December 31,             2021      2020             U.S. dollars in thousands       Other payables – Officers and Directors     $65      $13             $65      $13",
    "scheduleoftransactionswithrelatedpartiestabletextblock": "For the year ended December 31,             2021      2020      2019             U.S. dollars in thousands       Salary fees(1)     $257      $126      $112       Directors consultancy fees(2)      29       28       27       Share based payment expense (refer to Note 9)      1,707       66       230             $1,993      $220      $369       (1) Number of related parties      3       1       1       (2) Number of directors      4       4       4",
    "disclosureoffairvalueofthewarrantswasmeasuredusingthemontecarlomodel": "December 13, 2021                     Expected volatility (a)      90.61%      Share price (d)      3.72       Risk-free interest rate (b)      1.30       Expected life (years) (c)      5",
    "closingforeignexchangerate": 1.13,
    "changeinpercentagesexchangerate": -7.3,
    "computersandperipheralsandequipment": 0.33,
    "officefurnitureandequipment": 0.07,
    "leaseholdimprovements": "The shorter of the lease term and the useful life",
    "cash": 693000,
    "governmentagencies": 102000,
    "currentprepaidexpenses": 132000,
    "otherreceivable": 76000,
    "tradeandotherreceivables": 310000,
    "costbalance": 8000,
    "amountsincurreddeferredacquisitioncostsarisingfrominsurancecontracts": 3000,
    "disposalscost": -9000,
    "rightofuseassets": 4000,
    "depreciationpropertyplantandequipment": 2000,
    "disposalsaccumulateddepreciation": -1000,
    "intangibleassetsandgoodwill": 4000,
    "shorttermemployeebenefitsaccruals": 115000,
    "currentaccruedexpensesandothercurrentliabilities": 443000,
    "otherpayables": 558000,
    "numberofsharesauthorised": 60000000,
    "numberofsharesissuedandfullypaid": 10943534,
    "numberofsharesissued": 10943534,
    "issuedforcashduringtheperiod": 2000000,
    "exerciseofsharewarrantsandoptionsduringtheyear": 3083940,
    "dilutiveeffectofconvertibleinstrumentsonnumberofordinaryshares": 276672,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.916,
    "exercisepriceshareoptionsgranted2019": 3.51,
    "sharepriceindollarspershare": 3.72,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0142,
    "descriptionofoptionlifeshareoptionsgranted": 10,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P5Y",
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 2.25,
    "numberofoptionsgranted": 424500,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 3.28,
    "numberofoptionsexpired": -20130,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 0.03,
    "numberofoptionsexercised": -1246440,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 0.07,
    "numberofoptionsoptionsoutstandingending": 634500,
    "numberofoptionsexercisable": 231749,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 0.47,
    "researchanddevelopmentexpense": 1969000,
    "financeexpenses": 341000,
    "subcontractorsandconsultants": 628000,
    "sharebasedcompensation": 1969000,
    "benefitspaidorpayable": 447000,
    "researchanddevelopmentexpenseothers": 38000,
    "researchanddevelopmentexpensestotal": 3082000,
    "professionalfeesexpense": 372000,
    "expensefromsharebasedpaymenttransactionswithemployees": 1849000,
    "salariesandsocialbenefits": 74000,
    "insuranceexpense": 68000,
    "travelexpense": 50000,
    "otherexpensebynature": 92000,
    "generalandadministrativeexpenses": 2505000,
    "revaluationofwarrants": 2732000,
    "reclassificationadjustmentsonexchangedifferencesontranslationnetoftax": 2732000,
    "insurancefinanceincomeexpensesfrominsurancecontractsissuedexcludedfromprofitorlossthatwillbereclassifiedtoprofitorlossnetoftax": -1152000,
    "reclassificationadjustmentsoninsurancefinanceincomeexpensesfrominsurancecontractsissuedexcludedfromprofitorlossnetoftax": -32000,
    "othercomprehensiveincomenetoftaxinsurancefinanceincomeexpensesfrominsurancecontractsissuedexcludedfromprofitorlossthatwillbereclassifiedtoprofitorloss": -2000,
    "shareofothercomprehensiveincomeofassociatesandjointventuresaccountedforusingequitymethodthatwillbereclassifiedtoprofitorlossnetoftax": -1186000,
    "tradeandothercurrentpayables": 65000,
    "amountspayablerelatedpartytransactions": 65000,
    "wagesandsalaries": 257000,
    "dividendspaid": 29000,
    "keymanagementpersonnelcompensationsharebasedpayment": 1707000,
    "purchasesofgoodsrelatedpartytransactions": 1993000,
    "numberofrelatedparties": 3000,
    "numberofdirectors": 4000,
    "netlossapplicabletoshareholdersofordinaryshares": -4041,
    "sharesofordinaryshareusedincomputingbasicanddilutednetlosspershare": 6243411,
    "netlosspershareofordinarysharebasicanddiluted": -0.65,
    "cashonhand": 10359000,
    "longtermdeposits": 39000,
    "liabilityinrespectofwarrants": 1828000,
    "totalnetexposureinstatementoffinancialpositioninrespectoffinancialassetsandfinanciallia": -8292000,
    "profitlossattributabletoownersofparent": 58000,
    "profitlossattributabletoordinaryequityholdersofparententityincludingdilutiveeffects": 58000,
    "warrantliability": 1828000,
    "financialliabilities": 1828000,
    "weightedaveragesharepriceshareoptionsgranted2019": 3.72,
    "ordinaryshares": 2000000,
    "sharepurchaseagreements": "a.",
    "exercisepricepershares": 0.67,
    "warrantstoinvestorsdescription": "In August and September 2021 after the said assignments,the Company received warrant exercise notices of 1,837,500 warrants, out of the total 2,130,000 warrants outstanding at thattime. The other 292,500 warrants that were not exercised were waived by their owners. As a result of the said exercises, the Companyreceived aggregate proceeds of $1,225 thousand.",
    "numberofsharesissuedbutnotfullypaid": 2000000,
    "tradablewarrants": 2000000,
    "warrantsexercisepricepershare": 6,
    "totalgrossconsideration": 12000000,
    "incrementalfairvaluegrantedmodifiedsharebasedpaymentarrangements": 4560000,
    "reserveofequitycomponentofconvertibleinstruments": 7440000,
    "shareissuerelatedcost": 2136000,
    "netproceedsfromoffering": 9864000,
    "exerciseofunderwritersoption": 3,
    "descriptionofemployeeshareoptionplan": "●900,000shares, plus●An annual increase to be added as of the first day ofthe Company’s fiscal year, beginning in 2022 and occurring each year thereafter through 2032, equal to 4% of the total number ofordinary shares issued and outstanding on a fully-diluted basis as of the end of the Company’s immediately preceding fiscal year(or such lesser number of shares, including no shares, determined by the board of directors in its sole discretion).",
    "commonstockcapitalharesreservedfutureissuance": 1151130,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailablegrant": 309630,
    "numberofsharesoptionsgrantedinsharebasedpaymentarrangement": 72000,
    "stockoptiongrantedsharepricedescription": "●10,500 options have an exercise price of $1.67 per share. Theoptions vest immediately upon an IPO.●6,000 options have an exercise price of $1.67 per share. Theoptions vest on December 15, 2021. ●6,000 options have an exercise price of $1.67 per share. Theoptions will on March 15, 2022.",
    "descriptionoftypesofwarrantiesandrelatedobligations": "the Company also granted 100,000warrants to the underwriters as non cash issuance cost compensation and the underwriter has exercised his option and purchased 300,000warrants (refer to Note 9(18)). These warrants are still outstanding as of December 31, 2021.",
    "weightedaveragecostofcapitalpercentage": 0.3,
    "reserveofsharebasedpayments": 557,
    "rentalexpense": 7000,
    "issuanceofwarrantsshares": 2000000,
    "percentageoftaxrates": 0.23,
    "gainslossesonchangeinvalueofforwardelementsofforwardcontractsbeforetax": 3960000,
    "entityregistrantname": "NeuroSense Therapeutics Ltd.",
    "tradingsymbol": "NRSN",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--12-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1875091,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-41084",
    "entityincorporationstatecountrycode": "L3",
    "entityaddressaddressline1": "11 HaMenofim Street",
    "entityaddressaddressline2": "Building B",
    "entityaddresscityortown": "Herzliya",
    "entityaddresspostalzipcode": 562,
    "entityaddresscountry": "IL",
    "contactpersonnelname": "Or Eisenberg",
    "cityareacode": 972,
    "localphonenumber": "9-7996183",
    "security12btitle": "Ordinary Shares, no par value per share",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorfirmid": 1057,
    "auditorname": "Somekh Chaikin",
    "auditorlocation": "Tel-Aviv, Israel"
  }
]